InvestorsHub Logo

WeeZuhl

08/01/18 8:39 AM

#36107 RE: Samsa #36106

Weez, you ask for the evidence to back up my statements yet you then do the exact thing. You make a statement saying no one is interested in Rexista or Regabatin. why do you make that statement? merely because no partnership has been signed yet? the company even stated they were exploring interested partners.







The company has been exploring for years now. Who are they, Indiana Jones? I'd say if there was any interest at all they would take even a bad deal for either drug before doing a reverse split. I listed specific reasons why no partnership is forthcoming for any of these drugs, but the ultimate proof is the reverse split. Literally anything else would be a better option, but here we are. There is no partnership because there is nothing worth partnering.







As to my proof, its simple. The warrants are now classified s shares and they increased the outstanding shares. that places them on the books which means shareholder equity. Just go back and read the PR associated with the with resale.






So, in other words, crap you made up. This is a nonsense idea without any evidence. That registration statement provides exactly zero dollars of shareholder equity. They need to raise enough money to have $2.5 million in the bank at all times on top of their operating expenses. Last time $4.8M was not enough to do the job. Look for a $5-6M financing just for next quarter. With SP in low 30's, that is at least 40% dilution in the next few weeks with more to come in the next few months.